The previous chapter was focused on the Ranbaxy deal and its aftermath, the rapid rise and fall of Fortis Healthcare and Religare and the introduction...
Newly-appointed board of Fortis Healthcare, which is in the process of finding an investor, has again deferred approval of quarterly and annual financial results for...